Trethera attending the 8th Annual Biotech Showcase 2016

Beverly Hills, CA, 4 January 2016 – Trethera, a biotechnology company focused on the discovery and development of innovative small molecules for the treatment of hematological and solid tumors will be attending Biotech Showcase, San Francisco, USA, 11th-13th January 2016. The Company’s targeted metabolic pathway therapy approach involves using a rationally-designed combination of two or three drugs from the very start of cancer treatment.